Endocrine Therapy Drugs (ETDs) are prescribed medications used as a part of cancer treatment to block the effect of estrogen or progesterone on cancer cells. They work by preventing hormones from fueling the growth of hormone-receptor-positive cancers like breast, prostate and ovarian cancer. The global Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at US$ 30434.86 Mn in 2023...
0 Commentarios
0 Acciones
1155 Views
0 Vista previa